جمعه 20 شهریور 1405
[Archive]
پذیرفته شده و در حال انتشار
برگشت به فهرست مقالات |
برگشت به فهرست نسخه ها
چکیده: (322 مشاهده)
Abstract
Background
One of the newly reported novel biomarkers is sex hormone-binding globulin (SHBG). Recently, it is considered as a potential predictor for type 2 diabetes mellitus (T2DM) and metabolic dysfunction. Polymorphism of SHBG gene may lead to changes in Serum SHBG levels which could lead to different metabolic conditions. This study aimed to investigate these associations in Iraqi population.
Methods
This was a case-control study by using 600 specimens. A quantitative enzyme-linked immunosorbent assay (ELISA) with other standardized laboratory techniques were used. By using TaqMan real-time polymerase chain reaction assays all genotyping for the polymorphisms [rs1799941 and rs6257] was performed. Chi-square test, multinomial logistic regression, two-way ANCOVA and ROC analysis was performed to assess statistical analysis.
Results
Serum SHBG concentrations steadily decreased along the metabolic continuum from healthy controls to individuals with IR and patients with T2DM (P < 0.001). After assessing genotype distributions, it was found that a significant differences (P < 0.001). rs1799941 AA and rs6257 CC genotypes were independently linked to T2DM susceptibility. Both polymorphisms independently significantly affected circulating SHBG concentrations (P = 4.7 × 10−12 and P = 0.03). SHBG demonstrated great discriminatory performance with area under the curve (AUC) of 0.928 (95% CI: 0.903–0.953) and this was used to differentiate T2DM from healthy controls
Conclusions
A significant association was observed between decreased circulating SHBG concentrations and metabolic changes or T2DM. Both concentrations of SHBG in serum and risk of T2DM are independently correlated with the SHBG polymorphisms rs1799941 and rs6257.
Background
One of the newly reported novel biomarkers is sex hormone-binding globulin (SHBG). Recently, it is considered as a potential predictor for type 2 diabetes mellitus (T2DM) and metabolic dysfunction. Polymorphism of SHBG gene may lead to changes in Serum SHBG levels which could lead to different metabolic conditions. This study aimed to investigate these associations in Iraqi population.
Methods
This was a case-control study by using 600 specimens. A quantitative enzyme-linked immunosorbent assay (ELISA) with other standardized laboratory techniques were used. By using TaqMan real-time polymerase chain reaction assays all genotyping for the polymorphisms [rs1799941 and rs6257] was performed. Chi-square test, multinomial logistic regression, two-way ANCOVA and ROC analysis was performed to assess statistical analysis.
Results
Serum SHBG concentrations steadily decreased along the metabolic continuum from healthy controls to individuals with IR and patients with T2DM (P < 0.001). After assessing genotype distributions, it was found that a significant differences (P < 0.001). rs1799941 AA and rs6257 CC genotypes were independently linked to T2DM susceptibility. Both polymorphisms independently significantly affected circulating SHBG concentrations (P = 4.7 × 10−12 and P = 0.03). SHBG demonstrated great discriminatory performance with area under the curve (AUC) of 0.928 (95% CI: 0.903–0.953) and this was used to differentiate T2DM from healthy controls
Conclusions
A significant association was observed between decreased circulating SHBG concentrations and metabolic changes or T2DM. Both concentrations of SHBG in serum and risk of T2DM are independently correlated with the SHBG polymorphisms rs1799941 and rs6257.
فهرست منابع
1. International Diabetes Federation. IDF and Sun Life partner to support type 2 diabetes risk reduction [Internet]. Brussels: International Diabetes Federation; 2026. Available from: IDF news article
2. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes: global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107-11. [DOI:10.2991/jegh.k.191028.001] [PMID]
3. Zhao X , An X , Yang Ch, Sun W, Ji H , Lian F . The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). 2023;14 [DOI:10.3389/fendo.2023.1149239] [PMID] [PMCID]
4. Petra PH. The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function. J Steroid Biochem Mol Biol. 1991; 40:735-53. [DOI:10.1016/0960-0760(91)90299-K] [PMID]
5. Szybiak-Skora W, Cyna W, Lacka K. New insights in the diagnostic potential of sex hormone-binding globulin (SHBG)-clinical approach. Biomedicines. 2025;13(5):1207. [DOI:10.3390/biomedicines13051207] [PMID] [PMCID]
6. Sepu N, Adeleye JO, Kuti MO. Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control. J Natl Med Assoc. 2021;113(3):285-93. [DOI:10.1016/j.jnma.2020.11.014] [PMID]
7. Paruk IM, Pirie FJ, Nkwanyana NM, Motala AA. Prevalence of low serum testosterone levels among men with type 2 diabetes mellitus attending two outpatient diabetes clinics in KwaZulu-Natal Pro vince. South Africa S Afr Med J. 2019;109(12): 963-70. [DOI:10.7196/SAMJ.2019.v109i12.013893] [PMID]
8. Zhang J, Li X, Cai Z, Li H, Yang B. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. Aging Male. 2020 ;23(5):607-18. [DOI:10.1080/13685538.2018.1557139] [PMID]
9. Franciele Porgere I, Martins Rocha B, Monteiro Escott G, Carolina Fagundes Silva L, Aparecida Correa Freitas P, Satleret F et al. Association of age and insulin resistance with sex hormone-binding globulin levels in healthy men. Arch Endocrinol Metab. 2025;69(4): e240360 [DOI:10.20945/2359-4292-2024-0360] [PMID] [PMCID]
10. Aydin B, Winters SJ. Sex hormone-binding globulin and metabolic syndrome in children and adolescents: a focus on puberty. Metabolites. 2025;15(8):494. [DOI:10.3390/metabo15080494] [PMID] [PMCID]
11. White MJ, Eren F, Agirbasli D, Williams SM. SHBG gene polymorphism (rs1799941) associates with metabolic syndrome in children and adolescents. PLoS One. 2015;10(2): e0116915. [DOI:10.1371/journal.pone.0116915] [PMID] [PMCID]
12. Ponomarenko M, Reshetnikov E, Churnosova M, Aristova I, Abramova M, Novakov V, et al. Genetic variants linked with the concentration of sex hormone-binding globulin correlate with uterine fibroid risk. Life (Basel). 2025;15(7):1150. [DOI:10.3390/life15071150] [PMID] [PMCID]
13. Nadhum Jawad Musafer K, Ali A, Ahmad Damitri Al Astani T, Mohammed Arafat H, Irfan Abdul Jalal M, Nor Arifin W,et al. Genetic variants associated with type 2 diabetes mellitus: a meta-analysis of Egyptian and Levant populations. Diabetol Metab Syndr. 2026;18:111 [DOI:10.1186/s13098-026-02103-5] [PMID] [PMCID]
14. American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(Suppl 1): S27-S40.
15. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, Quintela AG. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47. [DOI:10.1186/1472-6823-13-47] [PMID] [PMCID]
16. Bourebaba N , Ngo T , Śmieszek A , Bourebaba L , Marycz K. Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment. Biomed Pharmacother. 2022; 153:113261. [DOI:10.1016/j.biopha.2022.113261] [PMID]
17. Shaherawala J, Mangukiya K. Study of various glycolytic inhibitors for preservation of blood glucose and clinical biochemical parameters.Int J Biochem Res. 2019;6(4):535-38 [DOI:10.18231/j.ijcbr.2019.112]
18. Dagur PK, McCoy JP Jr. Collection, storage, and preparation of human blood cells. Curr Protoc Cytom. 2015; 73:5.1.1-5.1.16. [DOI:10.1002/0471142956.cy0501s73] [PMID] [PMCID]
19. Jiang Z, Lu Y, Shi M, Li H, Duan J, Huang J. Effects of storage temperature, storage time, and hemolysis on the RNA quality of blood specimens: a systematic quantitative assessment. Heliyon. 2023;9: e16234. [DOI:10.1016/j.heliyon.2023.e16234] [PMID] [PMCID]
20. Chang J, Choi S, Cho H, Kim S, Chung JW, Yoo SJ, et al. Standards and practice guidelines for venous blood collection: consensus recommendations from the Korean Society for Laboratory Medicine. Ann Lab Med. 2025;45(4):343-57. [DOI:10.3343/alm.2025.0022] [PMID] [PMCID]
21. Roche Diagnostics. COBAS INTEGRA® 400 plus Operator's Manual.Mannheim, Germany: Roche Diagnostics.
22. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM,et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308-11. [DOI:10.1093/nar/29.1.308] [PMID]
23. Mansoori B, Liang C. Protocol for rapid allelic discrimination qPCR genotyping of the Winnie mouse model. STAR Protoc. 2026;7(2):104497. [DOI:10.1016/j.xpro.2026.104497] [PMID] [PMCID]
24. Fodor Duric L, Čolak Romić Z, Pavičić D, Čurić J, Belčić V, Rajković I, et al. The role of sex hormone-binding globulin (SHBG) as a marker of metabolic dysfunction-associated steatotic liver disease, with an extended analysis in both men and women. J Clin Med. 2026;15(3):1301. [DOI:10.3390/jcm15031301] [PMID] [PMCID]
25. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 361(12):1152-63. [DOI:10.1056/NEJMoa0804381] [PMID]
26. Narinx N, David K, Walravens J, Vermeersch P, Claessens F, Fiers T,et al. Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. Cell Mol Life Sci. 2022; 79(11):543. [DOI:10.1007/s00018-022-04562-1] [PMID] [PMCID]
27. Le TN, Nestler JE, Strauss JF, Wickham EP. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab. 2012;23(1):32-40. [DOI:10.1016/j.tem.2011.09.005] [PMID] [PMCID]
28. Komurcu-Bayrak E. Impact of genetic polymorphisms on insulin resistance. In Tech; 2012. [DOI:10.5772/51595]
29. Perry JRB, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, Sparsø T, et al. Genetic evidence that raised sex hormone-binding globulin levels reduce the risk of type 2 diabetes. Hum Mol Genet. 2010;19(3):535-44. [DOI:10.1093/hmg/ddp522] [PMID] [PMCID]
30. Chen C, Smothers J, Lange A, Nestler JE, Strauss JF III, Wickham EP III. Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome. Minerva Endocrinol. 2010;35(4):271-80.
31. Quan L, Wang L, Wang J, Yuwen B, Zhang J. Association between sex hormone-binding globulin gene polymorphism and type 2 diabetes mellitus. Int J Clin Exp Pathol. 2019;12(9):3514-20.
32. Huang R, Wang Y, Yan R, Ding B, Ma J. Sex hormone-binding globulin is an independent predictor for insulin resistance in male patients with newly diagnosed type 2 diabetes mellitus. Diabetes Ther. 2023;14(8):1627-37. [DOI:10.1007/s13300-023-01445-x] [PMID] [PMCID]
33. White MJ, Eren F, Agirbasli D, Williams SM, Agirbasli M. SHBG gene polymorphism (rs1799941) associates with metabolic syndrome in children and adolescents. PLoS One. 2015;10(2): e0116915. [DOI:10.1371/journal.pone.0116915] [PMID] [PMCID]
34. Sunbul M, Eren F, Nacar C, Agirbasli D. Sex hormone-binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women. Cardiol J. 2013;20(3):287-93 [DOI:10.5603/CJ.2013.0074] [PMID]
35. Longcope C, Feldman HA, McKinlay JB, Araujo AB. Diet and sex hormone-binding globulin. J Clin Endocrinol Metab. 2000;85(1):293-96. [DOI:10.1210/jcem.85.1.6291] [PMID]
36. AlAnazi M, Flores Ventura E, Lovegrove J, Santhanakrishnan Vimaleswaran K. A systematic review of the gene-lifestyle interactions on metabolic disease-related outcomes in Arab populations. Nutrients. 2024;16(15):2519. [DOI:10.3390/nu16152519] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
